Source link : https://www.newshealth.biz/health-news/alternative-pathway-inhibition-makes-good-in-iga-nephropathy/
SAN DIEGO — There was a clinically meaningful reduction in proteinuria with iptacopan (Fabhalta), and a confirmed clinical benefit of alternative pathway inhibition, in a rare kidney disorder, according to an interim analysis of the APPLAUSE-IgAN study. In the phase III study, among the first 250 patients with IgA nephropathy who underwent randomization, the adjusted […]
Author : News Health
Publish date : 2024-10-26 21:31:06
Copyright for syndicated content belongs to the linked Source.